Hypoxia regulates insulin receptor substrate-2 expression to promote breast carcinoma cell survival and invasion

Katerina Mardilovich1, Leslie M Shaw

  • 1Department of Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusett 01605, USA.

Cancer Research
|November 19, 2009
PubMed

Insights

Hypoxia, a low-oxygen state, increases the expression of insulin receptor substrate-2 (IRS-2). This enhances tumor cell survival and invasion, contributing to aggressive cancer behavior.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Insulin receptor substrate-2 (IRS-2) is an adaptor protein crucial for signaling pathways.
  • IRS-2 is implicated in cancer progression and aggressive tumor behavior.
  • Hypoxia is a common feature in tumors, influencing cancer cell phenotypes.

Purpose of the Study:

  • To investigate the regulation of IRS-2 by hypoxia.
  • To determine the role of IRS-2 in mediating hypoxia-induced signaling.
  • To elucidate the contribution of IRS-2 to the aggressive behavior of hypoxic tumor cells.

Main Methods:

  • Analysis of IRS-2 expression under hypoxic conditions.
  • Investigation of hypoxia-inducible factor (HIF) dependent regulation of IRS-2.
  • Assessment of IRS-2's role in insulin-like growth factor I (IGF-I) signaling and Akt activation.
  • Functional assays evaluating breast carcinoma cell survival and invasion in hypoxia.

Main Results:

  • IRS-2 expression, unlike IRS-1, is upregulated by hypoxia.
  • IRS-2 is identified as a novel hypoxia-responsive gene, with transcription regulated by HIF.
  • IRS-2 mediates IGF-I-dependent signals in hypoxia, and enhanced Akt activation is IRS-2 dependent.
  • Elevated IRS-2 expression promotes breast carcinoma cell survival and invasion under hypoxic conditions.

Conclusions:

  • IRS-2 is a key mediator of hypoxia-driven signaling in cancer.
  • IRS-2 upregulation by hypoxia contributes to increased metastatic potential.
  • Targeting IRS-2 may offer a therapeutic strategy for hypoxic tumors.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...